Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock
- PMID: 22683055
- PMCID: PMC3538477
- DOI: 10.1016/j.mayocp.2012.01.018
Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock
Abstract
Objective: To determine the frequency and spectrum of myocardial dysfunction in patients with severe sepsis and septic shock using transthoracic echocardiography and to evaluate the impact of the myocardial dysfunction types on mortality.
Patients and methods: A prospective study of 106 patients with severe sepsis or septic shock was conducted from August 1, 2007, to January 31, 2009. All patients underwent transthoracic echocardiography within 24 hours of admission to the intensive care unit. Myocardial dysfunction was classified as left ventricular (LV) diastolic, LV systolic, and right ventricular (RV) dysfunction. Frequency of myocardial dysfunction was calculated, and demographic, hemodynamic, and physiologic variables and mortality were compared between the myocardial dysfunction types and patients without cardiac dysfunction.
Results: The frequency of myocardial dysfunction in patients with severe sepsis or septic shock was 64% (n=68). Left ventricular diastolic dysfunction was present in 39 patients (37%), LV systolic dysfunction in 29 (27%), and RV dysfunction in 33 (31%). There was significant overlap. The 30-day and 1-year mortality rates were 36% and 57%, respectively. There was no difference in mortality between patients with normal myocardial function and those with left, right, or any ventricular dysfunction.
Conclusion: Myocardial dysfunction is frequent in patients with severe sepsis or septic shock and has a wide spectrum including LV diastolic, LV systolic, and RV dysfunction types. Although evaluation for the presence and type of myocardial dysfunction is important for tailoring specific therapy, its presence in patients with severe sepsis and septic shock was not associated with increased 30-day or 1-year mortality.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Right Ventricular Dysfunction in Early Sepsis and Septic Shock.Chest. 2021 Mar;159(3):1055-1063. doi: 10.1016/j.chest.2020.09.274. Epub 2020 Oct 14. Chest. 2021. PMID: 33068615 Free PMC article.
-
Characterization of Myocardial Dysfunction in Fluid- and Catecholamine-Refractory Pediatric Septic Shock and Its Clinical Significance.J Intensive Care Med. 2019 Jan;34(1):17-25. doi: 10.1177/0885066616685247. Epub 2016 Dec 29. J Intensive Care Med. 2019. PMID: 28030994
-
Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: a systematic review and meta-analysis.J Crit Care. 2014 Aug;29(4):495-9. doi: 10.1016/j.jcrc.2014.03.007. Epub 2014 Mar 21. J Crit Care. 2014. PMID: 24746109 Review.
-
Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*.Crit Care Med. 2014 Apr;42(4):790-800. doi: 10.1097/CCM.0000000000000107. Crit Care Med. 2014. PMID: 24365861
-
Basic and advanced echocardiographic evaluation of myocardial dysfunction in sepsis and septic shock.Anaesth Intensive Care. 2018 Jan;46(1):13-24. doi: 10.1177/0310057X1804600104. Anaesth Intensive Care. 2018. PMID: 29361252 Review.
Cited by
-
Prognostic value of right ventricular free wall strain in patients with sepsis.Front Cardiovasc Med. 2024 Feb 21;11:1334759. doi: 10.3389/fcvm.2024.1334759. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38450378 Free PMC article.
-
Inhibition of Pyruvate Dehydrogenase Kinase 4 Protects Cardiomyocytes from lipopolysaccharide-Induced Mitochondrial Damage by Reducing Lactate Accumulation.Inflammation. 2024 Feb 24. doi: 10.1007/s10753-024-01981-z. Online ahead of print. Inflammation. 2024. PMID: 38401019
-
Bisphosphoglycerate mutase predicts myocardial dysfunction and adverse outcome in sepsis: an observational cohort study.BMC Infect Dis. 2024 Feb 7;24(1):173. doi: 10.1186/s12879-024-09008-6. BMC Infect Dis. 2024. PMID: 38326761 Free PMC article.
-
Research Progress on the Mechanism and Management of Septic Cardiomyopathy: A Comprehensive Review.Emerg Med Int. 2023 Nov 20;2023:8107336. doi: 10.1155/2023/8107336. eCollection 2023. Emerg Med Int. 2023. PMID: 38029224 Free PMC article. Review.
-
Dose-related effects of norepinephrine on early-stage endotoxemic shock in a swine model.J Intensive Med. 2023 Sep 9;3(4):335-344. doi: 10.1016/j.jointm.2023.06.007. eCollection 2023 Oct 31. J Intensive Med. 2023. PMID: 38028636 Free PMC article.
References
-
- Hochstadt A., Meroz Y., Landesberg G. Myocardial dysfunction in severe sepsis and septic shock: more questions than answers? J Cardiothorac Vasc Anesth. 2011;25(3):526–535. - PubMed
-
- Parker M.M., Shelhamer J.H., Bacharach S.L. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100(4):483–490. - PubMed
-
- Vieillard-Baron A., Caille V., Charron C., Belliard G., Page B., Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med. 2008;36(6):1701–1706. - PubMed
-
- Bouhemad B., Nicolas-Robin A., Arbelot C., Arthaud M., Feger F., Rouby J.J. Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med. 2008;36(3):766–774. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
